Brief: India’s Strides Pharma Science June-Quarter Consol Net Loss Narrows
02/08/2023 07:43
Aug 2 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* JUNE-QUARTER CONSOL NET LOSS 71.1 MILLION RUPEES VERSUS
LOSS
1.36 BILLION RUPEES
* JUNE-QUARTER CONSOL REVENUE FROM CONTINUING OPERATIONS 9.3
BILLION RUPEES VERSUS 9.40 BILLION RUPEES
Source text for Eikon: ID:nBSEc0JvdX
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees